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FRETThe epidermal growth factor receptor (EGFR) is a well-studied receptor tyrosine kinase and an important anti-
cancer therapeutic target. The activity of EGFR autophosphorylation and transphosphorylation, which induces
several cell signaling pathways, has been suggested to be related to its oligomeric state. However, the oligomeric
states of EGFRs induced by EGF binding and the receptor–ligand stoichiometry required for its activation are still
controversial. In the present study, we performed Förster resonance energy transfer (FRET) measurements by
combining the coiled-coil tag–probe labeling method and spectral imaging to quantitatively analyze EGFR oligo-
merization on living CHO-K1 cell membranes at physiological expression levels. In the absence of its ligands,
EGFRs mainly existed as monomers with a small fraction of predimers (~10%), whereas ~70% of the EGFRs
formed dimers after being stimulatedwith the ligand EGF. Ligand-induced dimerization was not signiﬁcantly af-
fected by the perturbation ofmembrane components (cholesterol ormonosialoganglioside GM3).We also inves-
tigated both dose and time dependences of EGF-dependent EGFR dimerization and autophosphorylation. The
formation of dimers occurred within 20 s of the ligand stimulation and preceded its autophosphorylation,
which reached a plateau 90 s after the stimulation. The EGF concentration needed to evoke half-maximum di-
merization (~1 nM) was lower than that for half-maximum autophosphorylation (~8 nM), which suggested
the presence of an inactive dimer binding a single EGF molecule.
© 2015 Elsevier B.V. All rights reserved.1. Introduction
The epidermal growth factor receptor (also called EGFR, ErbB1, or
HER1) is one of the most well-studied receptor tyrosine kinases related
to cell differentiation, proliferation, and other physiological activities via
several signaling pathways, including the MAPK (mitogen-activated
protein kinase) pathway [1]. EGFRs are important anticancer therapeu-
tic targets because certain cancer tissues overexpress them, frequently
with aberrant mutations [2–4]. The intracellular signaling pathways ac-
tivated by EGFRs are triggered by homo/heterooligomerization between
EGFRs or an EGFR and other ErbB family receptors, which results in the
autophosphorylation/transphosphorylation of tyrosine residues at the C
terminus of the receptors [5–7]. Previous studies using X-ray crystallog-
raphy suggested that the extracellular domains of EGFRs maymarkedly
change from a tethered form [8] to an extended formwhen EGFRs bind
to their ligands: epidermal growth factor (EGF) or transforming growth
factor-α [9,10]. However, the actual behavior of EGFRs on cell mem-
branes upon ligand binding is more complex than a simple transition
from unliganded inactive monomers to liganded active dimersr; EGF, epidermal growth factor;
ctivated protein kinase.
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atsuzaki).[11–13]. Although the size of EGFR clusters is controversial, it is gener-
ally accepted that EGF binding enhances receptor oligomerization,
which activates receptors. Several studies reported that some EGFRs
could form inactive dimers (predimer), even in the absence of a ligand
[14–16]. EGFR dimers, higher-order oligomers, and aggregates have
been identiﬁed in the activation process [15,17]. Furthermore, there
are a number of possibilities for stoichiometry of ligand and receptor
that is required for the signaling. One reason for the inconsistency in
oligomeric states in the literature is the differences in the experimental
conditions such as the host cells used and expression levels of the recep-
tors. For example, the dimer fraction in the absence of ligands can de-
pend on the total concentration of receptors in the membrane because
the unoccupied EGFRmonomer is generally in equilibriumwith the un-
occupied EGFR dimer [13]. Another reason for the apparent diversity
has been attributed to limitations in the conventional methods used to
evaluate the oligomerization of membrane proteins. The solubilization
by detergents or ﬁxation of cells has been shown to signiﬁcantly perturb
interprotein interactions in native cell membranes [14,15]. For living
cell analyses, energy transfer methods using genetic luminescent/
ﬂuorescent proteins sometimes provide controversial ﬁndings on the
oligomeric states of target proteins because of a limited ability to control
the labeling ratio of the energy donor to the acceptor [18].
We here used EGFRs labeled with ﬂuorophores by coiled-coil label-
ing [19] to clarify the oligomeric states of EGFRs in the activation
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speciﬁc noncovalent bond between the E3-peptide (EIAALEK)3 fused
to the N-terminus of the target protein and the ﬂuorophore-
conjugated K4-peptide (KIAALKE)4 (total size, 5–6 kDa). This small
post-translational labeling method can speciﬁcally detect cell-surface
proteins in living cells. We recently reported that a combination of the
coiled-coil labeling method and Förster resonance energy transfer
(FRET) measurements by spectral imaging enabled an exact analysis
of the oligomeric states of targetmembrane proteins [20]. In the present
study, we examined the relationship between the oligomeric states of
EGFRs and their autophosphorylation levels to elucidate the activation
mechanism.2. Materials and methods
2.1. Preparation of K4 probes
The K4 peptide (KIAALKE)4 was synthesized using a standard 9-
ﬂuorenylmethyloxycarbonyl-based solid-phase method [19]. Each
ﬂuorophore (Alexa Fluor 568, Alexa Fluor 647, Tetramethylrhodamine,
or Cy5 (Life Technologies, Carlsbad, CA)) was added to the N-terminus
of the K4 peptide on resin by treating the ﬂuorophores with succinimidyl
ester derivatives [19]. After the ﬂuorophore-conjugated peptides had
been puriﬁed by reversed-phase HPLC, their molecular masses were
conﬁrmed by MALDI (Matrix-assisted laser desorption/ionization)
mass spectroscopy. The concentrations of the K4 probes were deter-
mined according to the absorbance of each ﬂuorophore.2.2. Plasmid construction
A DNA plasmid coding rat EGFR was constructed based on pcDNA3
(Life Technologies) by inserting the sequence of the E3-tagged EGFR
(signal sequence-E3 tag-linker (ggcggcggcatcgat)-rat EGFR sequence-
stop codon) at themulticloning site (see Table A1 in the SupportingMa-
terial). Rat EGFRwas cloned from the rat brain (see supplemental infor-
mation). Other pcDNA3-based plasmids containing E3-GpA* (G83I
mutant) and E3-M2 were constructed as described previously [20]. A
stable Flp-in CHO (Chinese hamster ovary) cell line expressing E3-
β2AR (1.3 × 105 receptors/cell) [21]was used as an expression standard.2.3. Cell culture
CHO cells, which have only negligible endogenous ErbB family re-
ceptors [22–25], were used for the transient expression of membrane
proteins. CHO-K1 and Flp-in CHO cells (Life Technologies) stably ex-
pressing E3-β2AR were cultured in Ham's F12 medium supplemented
with 10% FBS, L-glutamine, penicillin, and streptomycin at 50 μg/mL at
37 °C in a 5% CO2 incubator.2.4. Transient transfection
CHO-K1 cells (1.0 × 105 per dish) were seeded in a 35-mm glass
bottom dish (Advanced TC treated, Greiner Bio-one, Germany) and a
polymer bottomdish for confocal imaging and immunoblotting, respec-
tively. The medium was changed to a serum-free medium after over-
night incubation, and the cells were incubated with a transfection
mixture composed of 1.0 μg of plasmid DNA, 4.0 μL of Lipofectamine
LTX (Life Technologies), and 400 μL of Opti-MEM (Life Technologies)
per dish. Themediumof the CHO-K1 cellswas changed to freshmedium
containing 10% FBS 5 h after the transfection. These cells were used in
experiments 18 h after the transfection. To eliminate the effects of
growth factors included in FBS, E3-EGFR-expressing cells were serum-
starved for at least 3 h before being examined.2.5. Immunoblotting
After the transfection, E3-EGFR-expressing cells were incubated
with or without rat EGF (Higeta Shoyu, Tokyo, Japan) in PBS(+)
(137 mM NaCl, 8.1 mM Na2HPO4, 2.68 mM KCl, 1.47 mM KH2PO4,
0.9 mM CaCl2, 0.33 mM MgCl2, pH 7.4) for 5 min. After removing PBS,
the cells were lysed with 500 μL lysis buffer (1% SDS, 1 mM sodium
orthovanadate, 10 mM Tris–HCl (pH 7.4), protease inhibitor cocktail
(Nacalai Tesque, Kyoto, Japan)) to stop the phosphorylation reaction.
Lysates were boiled for 5 min and centrifuged (21,900 g, 5 min). Three
microliters of each supernatant was dropped on to the PVDF mem-
branes. After drying, the PVDF membranes were treated with the p-
EGFR (Tyr1173) antibody (sc-101668, Santa Cruz Biotechnology, Dallas,
TX) or EGFR antibody (sc-373746, Santa Cruz). The secondary antibody
labeled with horseradish peroxidase (anti-rabbit (sc-2004) or anti-
mouse (sc-2005), Santa Cruz) was then added, and immunoreactive
species were detected by the ECL reagent (Nacalai Tesque). The
phosphorylated-EGFR/total EGFR ratios of chemiluminescence intensi-
ties were used as the phosphorylation level. In Western blotting, 20 μL
of each lysate was applied to a 7% polyacrylamide gel. After SDS–
PAGE, the separated proteins were transferred onto PVDF membranes,
which were then treated in the same manner as described above.
2.6. Confocal microscopy
All imaging experiments were performed using a Nikon C1 confocal
microscope (Nikon, Tokyo, Japan) under a water-immersed 60×
objective (Plan Apo VC) with 561 nm and 637 nm lasers at room tem-
perature (25–30 °C). Cells expressing E3-tagged membrane proteins
were labeled with a mixture of donor and acceptor ﬂuorophores
(Alexa568 and Alexa647) conjugated with K4 probes in PBS(+)
(pH 7.4) for 5 min at room temperature after washing the cells once
with PBS(+). The proteinswere labeled at various donormole fractions
(XD) and excited at 561 nm to obtain ﬂuorescence emission spectra
from the cell membranes 3 μm above the glass surface. Spectral images
in 565–745 nm (resolution: 10 nm) were obtainedwith a spectrum de-
tector for following analysis of Eapp values. In the binding assay of K4
probes to the E3 tag fused with EGFR or β2AR, confocal images were ob-
tainedwith a standard detector through a BP575 to 615nmemission ﬁl-
ter for the donor and an LP650 nm emission ﬁlter for the acceptor.
2.7. Analysis of Eapp values from observed spectra
We analyzed the oligomeric states of E3-tagged membrane proteins
using FRET spectroscopy, as described in a previous study [20]. Brieﬂy,
we calculated FRET efﬁciencies based on sensitized emission of the
acceptor ﬂuorophores (Alexa647 or Cy5) from cell membranes. For
the deconvolution of the observed spectra into donor and acceptor
spectra, we separately obtained the reference spectra of the donor excit-
ed at 561 nm and acceptor excited at 637 nm from E3-GpA* (G83I
mutant)-CHO (transient). We use the least-squares method to perform
deconvolution (see Fig. A4 and ref. [23]). Values of the apparent FRET ef-
ﬁciency based on sensitized acceptor emission (Eapp) were calculated
with the equation based on the theory of Meyer et al. [26]
Eapp ¼
εA λ
ex
D
 
εD λ
ex
D
  FAD−FA
FA
 
ð1Þ
where εA(λDex) and εD(λDex) represent the molar extinction coefﬁcient of
the acceptor and donor at 561 nm, respectively, and FAD and FA indicate
the acceptor emission intensity (arbitrary unit) excited at 561 nm in the
presence and absence of the donor, respectively. Because FA could not be
directly acquired in the presence of the donor, we also measured the
ratio of the ﬂuorescence intensities of the acceptor excited at 561 and
637 nm (R561/637) from the E3-GpA mutant (G83I)-CHO (transient)
Fig. 1.Confocal images of E3-tagged proteins. Representative spectral images are shown in
a pseudocolor. E3-tagged proteinswere transiently expressed and labeledwith a 1:1mix-
ture of a donor (Alexa568-K4) and acceptor (Alexa647-K4) (XD = 0.5) in PBS (+)
(pH 7.4). The total K4 probe concentration was 100 nM (EGFRs) or 50 nM (the other pro-
teins). All imageswere captured 5–25min after labeling. GpA* as a standard of amonomer
is the G83Imutant of glycophorin A,whichwas derived fromhuman erythrocytes.M2 as a
standard of a dimer is the M2 proton channel derived from inﬂuenza A virus. Rat EGFRs
were stimulated with 150 nM of rat EGF. Scale bar = 20 μm.
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ty of the acceptor acquired by the excitation at 637 nm in the presence
of the donor by the R561/637 ratio to obtain the FA value.
2.8. Theoretical curves
Taking into account of random labeling of the donor and acceptor in
the oligomers, the theoretical curve for Eapp is given [26] as
Eapp ¼ E 
XD
1−XD
 1− XD 1−X0U
 þ X0U 	N−1
h i
ð2Þ
where XD, X′U, and N indicate the donor molar fraction over the total
(donor and acceptor) molar concentration of the K4 probes, unlabeled
receptor fraction, and the number of protomers in an oligomer, respec-
tively. The total molar concentrations of the K4 probes were set such
that labeling efﬁciencies would be approximately 90% (100 nM for E3-
EGFR and 50 nM for the other proteins). The X′U value was estimated
to be 0.1 based on the occupancies (~90%) of E3-taggedmembrane pro-
teins labeled with K4 probes at 50 nM (in the case of E3-β2AR /GpA*/
M2) or 100 nM (E3-EGFR). E represents the true FRET efﬁciency in the
oligomers, which was determined by the distance and mutual orienta-
tion of the donor and acceptor. The assumption of a random orientation
of theﬂuorophoreswas reasonable because ofﬂexible linkers (Gly–Gly–
Gly–Ile–Asp) between the E3 tag and N-terminal regions.
2.9. Depletion of sialic acid and cholesterol
After transient transfection, E3-EGFR-expressing CHO-K1 cells were
incubated for 2 h in serum-free medium, and then treated with 20 or
100mU/mL of Arthrobacter ureafaciens neuraminidase (Nacalai Tesque)
in serum-free medium for 1 h at 37 °C to deplete sialic acid levels. To
metabolically deplete cellular cholesterol, CHO-K1 cells were incubated
with 1 μM compactin from seeding to examination, expect for the
incubation time, with serum-free medium for 5 h after the transient
transfection of EGFR. Other procedures were the same as other FRET
experiments.
2.10. Time course of the FRET signal
Time-lapse images were acquired to detect the time course of the
EGFR oligomerization induced by the EGF stimulation. After staining
cells with Alexa-labeled K4 probes at XD = 0.5 in 1 mL PBS(+)
(pH 7.4) for 5 min at room temperature after washing the cells once
with PBS(+), confocal images were obtained under excitation at
561 nm at 25–30 °C. After taking the ﬁrst three images (4 s intervals),
1 mL of PBS(+) containing the K4 probe (ﬁnal concentration of
100 nM) and EGF (ﬁnal concentration of 150 nM) was rapidly mixed
with the sample, followed by the taking of images (2 s intervals). The
ﬂuorescence spectra from cell membranes at each time point were
deconvoluted into donor and acceptor spectra. The ratio of themaximal
ﬂuorescence intensity of the acceptor (Em: 665 nm) to donor (Em:
605 nm) (=A/D) was used as a measure of FRET.
3. Results
3.1. EGFR expression and EGF-induced autophosphorylation
Western blot analyses were performed to examine the expression of
EGFRs and their phosphorylation activities in CHO-K1 cells. E3-EGFRs
were detected as single bands at approximately 175 kDa with both
the anti-total EGFR antibody and anti-phosphotyrosine 1173 antibody
(see Fig. A1). The intensities of the phosphorylated bands increased
with increases in the concentration of EGF. We conﬁrmed that dot
blotting gave similar results to Western blotting (see Fig. A1). Weperformed dot blotting in subsequent experiments to determine the
autophosphorylation levels of EGFRs.
3.2. Labeling of EGFRs using the coiled-coil method
CHO-K1 cells expressing E3-fused EGFRs were imaged by confocal
microscopy after the speciﬁc labeling of cell-surface receptors with K4
probes (Fig. 1). Most receptors remained in the plasmamembrane dur-
ing the observation time (5–25 min after incubation with or without
EGF), although EGF stimulation enhanced internalization (Fig. 1). We
analyzed the ﬂuorescence spectra in the cell membrane region in the
following experiments. The KD values between ﬂuorophore-labeled K4
probes and E3-fused EGFRs (6–8 nM) were similar to those for other
E3-tagged membrane proteins used in previous studies (~5 nM) (see
Fig. A2). To conﬁrm that the E3–K4 complex did not affect EGFR activa-
tion, we examined EGF-induced EGFR autophosphorylation with and
without K4 probes by immunoblotting. No signiﬁcant difference was
observed with the addition of K4 probes (see Fig. A3).
3.3. Analysis of oligomeric states
To detect FRET induced by receptor oligomerization, we co-labeled
E3-fused proteins on the cell surface with a pair of ﬂuorophores with
a large critical distance transfer (Alexa568 and Alexa647, R0 = 82 Å)
at various donor mole fractions (XD). After the acquisition of spectral
images by confocal microscopy, ﬂuorescent spectra from the cell mem-
branes (Fig. 2A) were used to calculate the apparent FRET efﬁciency
(Eapp) (Eq. (1)). Amonomeric standard E3-GpA* (G83Imutant) showed
Eapp values of nearly zero independent of XD, whichwas consistent with
monomers (Fig. 2B). We used the E3-M2 proton channel derived from
inﬂuenza A virus as a dimer standard because we recently found that
E3-M2 formed dimers at pH 7.4 [27]. These proteins were always used
as monomer and dimer standards to conﬁrm the reliability of the Eapp
values of E3-EGFR. We could determine Eapp values with an accuracy
of ± 0.1 [20]. In the FRET analysis, we selected cells expressing a phys-
iological level of EGFRs (5 × 104–2 × 105 receptors/cell) by comparing
ﬂuorescence intensities with those for reference cells stably expressing
E3-β2AR (1.3 × 105 receptors/cell) [20] (see Fig. A5). Eapp values for E3-
EGFR were 0.1 or lower in the absence of EGF (Fig. 2C). On the other
hand, in the presence of a saturating amount of EGF (150 nM), Eapp
Fig. 2.Detection of the oligomeric states of membrane proteins by FRET. (A) Fluorescence spectra (Ex : 561 nm) from cellmembranes labeledwith the Alexa pair (XD= 0.5). Fluorescence
spectra from at least 10 cells were averaged and normalized at 605 nm. Labeling conditions were the same as those described in Fig. 1. The symbols indicate a GpA G83I mutant (black
squares), M2 proton channel (blue squares), EGFRwithout EGF (red open circles), and EGFR with 150 nM EGF (red solid circles). (B) Theoretical curves andmeasured Eapp values at various
donor mole fractions (XD) using K4 probes labeled with the Alexa pair. Black, blue, green, and yellow lines show theoretical curves for monomers, dimers, trimers, and tetramers, respec-
tively. N indicates the number of protomers in an oligomer. Black and blue squares indicate the Eapp values for GpA* and M2, respectively (n N 10). (C) The Eapp values for EGFR with or
without 150 nM EGF using K4 probes labeled with the Alexa pair. Open and solid circles indicate values in the absence and presence of EGF, respectively (n N 10). The plots were linearly
ﬁt to obtain the slopes. (D) Comparison of Eapp values for EGFR labeledwith the Alexa pair (red) and the TMR–Cy5 pair (green). Open and solid symbols indicate values in the absence and
presence of EGF, respectively (n N 10).
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0.55 ± 0.03, which was lower than the theoretical value for the dimer
with E= 1 (0.9). The FRET signals already reached plateau 2 min after
stimulation (see Fig. 4) and did not change signiﬁcantly 5–25 min
after the EGF stimulation (data not shown). Partial dimerization (coex-
istence of monomers and dimers) and/or a larger donor–acceptor sepa-
ration in the dimer than the R0 value of 82 Å (E b 1) may decrease the
Eapp value of stimulated EGFRs. To clarify the contributions of these
two possibilities, we performed FRET experiments using another pair
of ﬂuorophores (TMR–Cy5), whose R0 value (53 Å) [28] was shorter
than that of the Alexa pair. In this case, the slope of Eapp was 0.25 ±
0.01 (Fig. 2D). Because of a theoretically linear relationship between
Eapp and XD, in the case of monomer–dimer transition, an observed
value of Eapp is proportional to a dimer fraction at each XD. The donor–
acceptor distance (R) and corrected dimer fraction of EGFRs (f) were es-
timated by solving simultaneous equations for the Alexa and TMR–Cy5
pairs as follows:
Slope ¼ f E 1−X0U
  ¼ f 0:9
1þ RR0
 6
0
B@
1
CA ð3Þ
We obtained R and f values of 56 Å and 0.67, respectively. The value
of Rwas plausible for a model that two K4 probes were tethered by the
coiled-coil labeling and freely moved around the N-termini of the EGFR
back-to-back dimer, as determined by X-ray crystallography (~50 Å)
[9]. One third of the EGFRs existed as monomers, even in the presenceof sufﬁcient EGF ligands. Note that the FRET results do not exclude the
possibility of local concentration (clustering) of the receptors intomem-
brane domains without close contacts of the receptors (E= 0).
3.4. Effects of membrane components on EGFR dimerization
Membrane components such as cholesterol and ganglioside GM3
have been considered as functional modulators for EGFRs and other
tyrosine-kinase receptors [29,30]. We examined the relationship be-
tween EGFR dimerization and the presence of cholesterol or GM3 by
measuring Eapp values at XD = 0.74 after the treatment with the lipid-
disrupting reagents. The compactin-induced depletion of cholesterol
had no signiﬁcant effect on the Eapp value in the presence of EGF
(Fig. 3). Similarly, the degradation of GM3 by the treatment with up to
100 mU/mL neuraminidase did not signiﬁcantly affect the Eapp value
with 150 nM EGF (Fig. 3).
3.5. Time course of EGFR oligomerization and phosphorylation
We detected rapid receptor oligomerization following ligand stimu-
lation with the acceptor/donor ﬂuorescence intensity ratio (A/D). Upon
adding EGF to cells, theA/D value increased from the baseline (~0.08) to
a plateau (~0.14) valueswithin 20 s (Fig. 4). The ratio did not change for
at least 3 min after reaching the plateau. On the other hand, the EGFR
phosphorylation level, examined by dot blotting, exhibited a slower in-
crease than the FRET signal, and reached a plateau at approximately 90 s
(Fig. 4). Note that the ligand-independent basal phosphorylation of
EGFR in the absence of EGF exhibited the non-zero value (0.2–0.4)
Fig. 3. Eapp values after the depletion of cholesterol or monosialoganglioside GM3. All ex-
periments were performed at XD= 0.74. Fluorescence spectra from EGF-stimulated CHO-
K1 cells were observed 5–25 min after the EGF stimulation. Each value indicates the
mean ± SE. (n N 10).
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which were excluded in the confocal microscopy-based analyses,
whereas ligand-induced phosphorylation should represent the re-
sponse from cells expressing physiological amount of receptors.
3.6. Dose–response curves
Finally,we examined the EGF concentration-dependence of EGFR di-
merization at XD = 0.74. We determined Eapp values of EGFRs after
5–25 min stimulation with different concentrations of EGF in the pres-
ence of the Alexa K4 probes pair. Percentages of EGFR dimers (dimer
fraction at each EGF concentration (f) × 100) were calculated as
f  100 ¼ Eapp; obs
Eapp; dimer
 100 ¼ Eapp; obs  100
E  XD
1−XD
 1− XD 1−X0U
 þ X0U 	
 
¼ 165:38 Eapp; obs ð4ÞFig. 4.Time courses of dimerization and phosphorylation upon stimulation.A/D is the ratio
of the maximal ﬂuorescence intensities of the acceptor (665 nm) to the donor (605 nm),
which were obtained from the deconvoluted ﬂuorescence spectra (Ex : 561 nm) of four
cell membranes. Labeling was performed at XD = 0.5. The phosphorylation level was
the relative chemiluminescence intensity for phosphorylated Tyr1173 to total EGFR as de-
termined by dot blotting after the stimulation was stopped at each time point by the ad-
dition of the lyse buffer. The phosphorylation level was an average from three separately
performed experiments. Each value indicates the mean ± SE. (n N 3).Where Eapp,obs is an observed value of Eapp, Eapp,dimer is the theoretical
value of Eapp considering all EGFRs formdimers. E (=1 / (1+ (R/R0)6) is
the true FRET efﬁciency in the dimer considering R = 56 Å and R0 =
82 Å. XD and X′U were ﬁxed at 0.74 and 0.1, respectively. The dimeriza-
tion of EGFRs signiﬁcantly increased in an EGF concentration range be-
tween 1 nM and 10 nM (an apparent 50% effective dose was ~1 nM)
(Fig. 5A). At higher concentrations of EGF (N10 nM), the fraction of
dimerized EGFRs was approximately 67% (55–75%). On the other
hand, an apparent 50% effective dose of EGFR phosphorylation deter-
mined by immunoblotting was ~8 nM (Fig. 5A).
4. Discussion
4.1. Oligomeric states of EGFRs
The mechanism underlying EGFR oligomerization is not simple be-
cause the strength of ligand afﬁnity and receptor self-association are in-
tricately related to each other. For example, negative cooperativity has
been reported for the ligand binding of EGFRs [11–13], which indicates
that EGFRs have two distinguishable binding sites to their ligand and
binding of the ligand to the ﬁrst site reduces afﬁnity for the second
site [13]. Moreover, the degree of oligomerization generally depends
on the expression level according to the association constants [13].
Under our experimental conditions (5 × 104–2 × 105 receptors/cell),
EGFRs appeared to exist as monomers or dimers without forming
higher-order oligomers because the Eapp plot of EGFR with 150 nM
EGF gave the best ﬁt with a linear shape (Fig. 2C and D), which is char-
acteristic of the dimer. On the other hand, downward-convex curves are
characteristic of the trimer or higher oligomers (Fig. 2B). Themajority of
EGFRs could be regarded as monomers in the resting state (~90%) with
a small fraction of predimers (~10%), whereas ~70% of the EGFRs
formed dimers after ligand stimulation. The observed degrees of oligo-
merization appear to be lower than those in previous reports describing
signiﬁcant formation of predimers and higher-order oligomers in the
absence of EGF [31,32]. The host cell line and the expression level can
signiﬁcantly affect the oligomeric and clustering states of the receptors.
Clayton and coworkers reported tetramers (or higher-order oligomers)
of unligated EGFR in epidermoid carcinomaA431 cells [31]. On the other
hand, Saffarian et al. [32] reported ~70% monomeric EGFRs in the rest-
ing state in CHO cells. In our experiments, the coiled-coil labeling may
slightly interfere the oligomerization to underestimate the oligomer
population, although the N-termini were separated in the dimer
(~56 Å, estimated from Eq. (3)), and the K4 labeling did not affect the
phosphorylation of the receptors (Fig. A3).
4.2. Factors affecting EGFR dimerization
Themonomer–dimer transition of EGFRsmay be regulated by sever-
al factors other than the receptor concentration. One possible reason
why not all EGFRs formed dimers following the EGF stimulation is the
interaction between plasmamembrane components andEGFRs. Choles-
terol and GM3 have been shown to interact with EGFRs, thereby
diminishing ligand-induced EGFR phosphorylation, whereas the re-
moval of cholesterol from cell membranes or degradation of GM3 in-
creased EGFR phosphorylation [29,30]. Therefore, it is plausible to
assume that these lipids suppress receptor oligomerization. However,
we observed no signiﬁcant effect of the depletion of cholesterol or
GM3 on the oligomeric states of EGFRs in the presence of 150 nM EGF
(Fig. 3). These results suggest that cholesterol and GM3 had no effect
on EGFR dimerization in ligand-occupied extended EGFRs. These results
indicate that these twomembrane components inhibit EGFR phosphor-
ylation by different mechanisms from the regulation of oligomeric
states. Other factors may explain the coexistence of EGFR monomers
and dimers after the ligand stimulation. The extracellular domain of
EGFRs may remain a steric hindrance to dimerization to some extent.
A previous study reported that an EGFR mutant lacking much of the
Fig. 5. EGF dose-dependent dimerization and phosphorylation of EGFRs. (A) The EGF concentration dependencies of EGFRs. Blue: Oligomerization 5–25 min after EGF stimulation. Red:
Phosphorylation 5 min after EGF stimulation of EGFRs. The phosphorylation level was obtained from dot blotting (see Fig. A1, B). The dimer fraction was calculated from Eapp values at
XD = 0.74, assuming R= 56 Å. Each value indicates the mean ± SE. (n N 10). (B) Proposed model for the activation of EGFRs induced by EGF.
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than that of the wild-type regardless of the ligand stimulation [33]. Fur-
thermore, the cationic residues of the kinase domain may interact with
anionic lipids (e.g., phosphatidylserine) on the inner leaﬂet to hinder
EGFR dimerization, although the intracellular domains of EGFRs also ex-
hibit dimerizing abilities [7]. EGFR phosphorylation can also enhance
the dissociation of dimers into monomers [13,34]. In the present
study, the ﬂuorescence spectra acquired from the cell membrane
contained temporally averaged information regarding the EGFR oligo-
meric state. Therefore, it remains unclear whether the coexistence of
monomers and dimers reﬂects two static species or a dynamic equilib-
rium between them. Single molecule studies reported that dimers
were not very stable (lifetimes in the order of seconds), even in the
ligand-bound form [35]. Therefore, at least some of the EGF-resistant
monomers observed should be in dynamic equilibrium with dimers.
4.3. Relationship between EGFR dimerization and phosphorylation
As far as we know, it is the ﬁrst time to investigate quantitatively
the relationship of time courses of the EGFR dimerization and auto-
phosphorylation induced by EGF stimulation. The receptors rapidly
oligomerized within 20 s after EGF stimulation (Fig. 4). EGF associa-
tion rate was estimated by using reported rate constants for high-
afﬁnity and low-afﬁnity sites [36,37]. In our condition of 150 nM
EGF, the observed oligomerization rate (k ~ 0.1 s–1, Fig. 4) was com-
parable or lower than the binding rates for both high-afﬁnity
(khigh = 0.23–60 s–1) and low-afﬁnity (klow = 0.084–0.6 s–1) sites, al-
though the formation of low-afﬁnity inactive dimer may prevent com-
plete ligand binding to all receptors (see below). The theoretical
random collision rate of EGFR monomers is sufﬁciently fast (k =
5.6 s–1) and can explain the quick dimerization under the experimental
conditions (calculated according to Eq. (13b) of reference [38], assum-
ing receptors per cell of 50,000with a cell diameter of 20 μm, critical col-
lision distance of 1 nm, and a diffusion coefﬁcient [35] of 0.05 μm2 s–1).
The delayed EGFR phosphorylation upon ligand binding revealed that
EGFR dimerization preceded its phosphorylation (Fig. 4). This ﬁnding
is consistent with the conventional view that EGFR autophosphoryla-
tion requires the formation of the asymmetric kinase domain dimers
[7].Moreover, as shown in Fig. 5A, the dose–response of EGFRdimeriza-
tion shifted to the left of the phosphorylation curve. Considering that a
subnanomolar range of EGF can trigger signiﬁcant signaling by binding
to the high-afﬁnity site [37,46], the saturation of phosphorylation
should require sufﬁcient EGF binding to the low-afﬁnity site, althoughit may not be related to signaling in physiological conditions. The appar-
ent 50% effective doses of EGFR dimerization and phosphorylationwere
approximately 1 nM and 8 nM, respectively, with the former being
within the reported apparent binding afﬁnities (KD) of EGFR to its ligand
(0.27–5 nM [39–43]). The latter less-sensitive phosphorylation activi-
ties have also been reported in literatures [44,45]. These results conﬁrm
that the N-terminal coiled-coil labeling did not signiﬁcantly affect the
receptor function. EGFRs were signiﬁcantly dimerized while maintain-
ing the basal phosphorylation level especially at 1 nM of EGF. A
formation of kinase-inactive dimers may explain the experimental ob-
servation. A possible model for this inactive dimer is an EGFR dimer
that binds to a single EGF, which can be activated by the binding of a
second ligand (Fig. 5B). A ligand-occupied EGFR monomer was more
likely to encounter an unoccupied monomer at EGF concentrations of
1–10 nM, and they could form an inactive dimer with a single ligand.
This observation is consistent with negative cooperativity for the ligand
binding to EGFRs [11–13]. On the other hand, other studies have shown
that low receptor occupancy is sufﬁcient to trigger signaling, suggesting
that EGF binding to high-afﬁnity receptors has positive cooperativity
[36,37,46]. We propose a hypothetical model to explain these observa-
tions. In this model, binding of an EGF to the predimer (~10% in this
study) accelerates binding of the second EGF and rapid activation
(high-afﬁnity dimer with positive cooperativity) [36], whereas associa-
tion of EGF-bound monomer to unbound monomer decelerates the
binding of the second ligand (ligand-induced low-afﬁnity dimer with
negative cooperativity) (Fig. 5B). In previous models, these single-
liganded dimers are not discriminated as different species [5,12,36,
47]. The interconversion between these species may be slowed down
due to steric hindrance in the dimers. Liu et al. [48] showed that EGFR
dimers occupied with a single EGF can be phosphorylated by means of
cotransfection of two kinds of EGFR mutants that lack the ligand-
binding or kinase activity, respectively, but they did not examine the
ratio of phosphorylated single-occupied dimers over all dimers in the
experimental condition. Moreover, a phosphorylation level of the
single-occupied dimer mutants was signiﬁcantly lower than that of
dimers of intact EGFRs in the presence of EGF. It is also unclear whether
the difference of phosphorylation levels between the single-occupied
dimer mutants in the presence and absence of EGF was signiﬁcant or
not in this report [48]. Considering the Liu's report, the single-
occupied dimers may have partial phosphorylation activity; however,
the main source of EGFR phosphorylation was the double occupied
dimers at least in the presence of 1 nM or higher concentrations of
EGF in our experimental conditions.
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We succeeded in elucidating the oligomeric states of EGFRs on living
CHO cell membranes using a combination of the coiled-coil method and
FRET analysis based on confocal spectral microscopy. Comparing with
other previous reports on EGFR activities, we emphasize that this ap-
proach is quantitative and enables time-resolved analysis for living
cells. Our results showed that the majority of EGFRs assumed a mono-
mer form in the absence of their ligands with a small fraction of
predimer (~10%). The ligand stimulation led to ~60% of EGFRs altering
their oligomeric state from monomers to dimers, while the remaining
receptors existed as monomers. The formation of dimers by the ligand
stimulation preceded its phosphorylation in both time and ligand-
dose dependent manners. These results indicate that the formation of
EGFR dimers induced by the ligand stimulation plays a major role in
EGFR autophosphorylation. Regarding the clinical importance of
EGFRs, several kinds of cancerous cells overexpress EGFRs (e.g., A431
cells (N2 × 106 receptors/cell) [49]) or have pathogenic EGFRmutations
[50]. The method used in this study could reveal the behavior of EGFRs
in the context of these malignant cells. Moreover, the coiled-coil label-
ing method could be applicable to other ErbB family receptors and
other membrane proteins, so this approach could help to understand
comprehensively the interactions of EGFRs and other relatedmembrane
proteins with high quantitative accuracy in the future.
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DNA oligonucleotide sequences for the construction of E3-ratEGFR-
pcDNA3 (Table A1), immunoblotting of EGFR (Fig. A1), binding assay
for K4 probes (Fig. A2), EGFR autophosphorylation activity with/
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